ReviewRole of interleukin-1β during pain and inflammation
Section snippets
Interleukin-1
Interleukin-1 α and β are prototypic proinflammatory cytokines that exert pleiotrophic effects on a variety of cells and play key roles in acute and chronic inflammatory and autoimmune disorders. There are two IL-1 receptors, IL-1 type 1 receptor (IL-1RI) and IL-1 type 2 receptor (IL-1 RII). IL-1α and IL-1β signal through IL-1RI. Binding to IL-1RII does not lead to cell signaling and it is therefore considered a decoy receptor. Upon binding of IL-1 to IL-1RI, a second receptor termed IL1
Inflammasome
The inflammasome is an intracellular multi-protein complex that is emerging as an important regulator of inflammation (Fig. 1). The inflammasome acts as an activating scaffold for proinflammatory Caspases. One such Caspase, Caspase 1, cleaves and activates pro-IL-1β and pro-IL-18 (reviewed in Martinon and Tschopp, 2007). IL-33 has also been shown to be a possible Caspase 1 substrate (Schmitz et al., 2005). Inflammasomes play important roles in the innate immunity pathway and are active players
IL-1β in gout and other autoinflammatory diseases
Recently, gouty arthritis has taken center stage in the inflammasome field. Gout is one of the most painful acute conditions known to man and has been described since Egyptian times (reviewed in Nuki and Simkin, 2006). Gout is an autoinflammatory disorder that is caused by hyperuricemia. Articular deposits of monosodium urate (MSU) crystals lead to gouty arthritis, which causes acute gout attacks. These attacks present clinically as a highly inflammatory arthritis with intense redness, warmth
IL-1β in the periphery and pain
IL-1β is a potent mechanical and thermal hyperalgesic agent when injected into any number of peripheral tissues (Ferreira et al., 1988, Fukuoka et al., 1994, Watkins et al., 1994, Safieh-Garabedian et al., 1995, Cunha et al., 2000, Zelenka et al., 2005). Intraplantar injection of inflammatory agents, such as carrageenan, lipopolysaccharide (LPS) bacterial endotoxin, or complete Freund's adjuvant (CFA), produce mechanical or thermal hyperalgesia associated with an upregulation of IL-1β and other
IL-1β's role during neuropathic pain
Neuropathic pain arises from dysfunction of the nervous system. The interplay between the immune and nervous systems is thought to be critical for the development and maintenance of neuropathic pain, and the proinflammatory cytokines, including IL-1β, appear to be contributory to the pain state (reviewed in Scholz and Woolf, 2007, Uceyler and Sommer, 2008). Low back pain is a common and debilitating painful disorder which can arise from nerve injury. In degenerate and herniated human
IL-1β in the CNS and pain
As suggested by the spinal cord data mentioned previously, the involvement of cytokines in persistent pain is not limited to peripheral sensitization. Proinflammatory cytokines and their receptors have been found in the CNS. For example, IL-1β's receptor IL-1R1 has been localized to the spinal dorsal horn and brain (Samad et al., 2001, Guo et al., 2007, Zhang et al., 2008).
Direct injection of IL-1β into the CNS has been shown to produce hyperalgesia and enhanced neuronal responses in animals (
IL-1β in central glia-neuronal interaction
Injury-induced central neuronal hyperexcitability, or central sensitization, has been identified as an important mechanism underlying persistent pain. Evidence suggests that glia, particularly astroglia, are intimately involved in the control of neuronal activity (Jourdain et al., 2007, Parri and Crunelli, 2007). Convergent evidence suggests that inflammatory cytokines act as mediators between glia and neurons and assume roles as neuromodulators (reviewed in Watkins and Maier, 2003).
IL-1β signaling, NMDA receptor phosphorylation, and persistent pain
Neuronal glutamate receptors, particularly ionotropic NMDA receptors, play major roles in activity-dependent synaptic plasticity and persistent pain (reviewed in Woolf and Salter, 2000, Guo et al., 2006, Ji and Woolf, 2001). NMDA receptors are heteromers of NR1/NR3 and NR2 subunits (reviewed in Paoletti and Neyton, 2007). Several amino acid residues on the intracellular C-termini of the NR1 and NR2 proteins are phosphorylated upon activation of protein kinases. These phosphorylation sites of
Conclusions
In summary, a growing number of studies show that peripheral injury activates both neuronal and non-neuronal or glial components of the peripheral and central cellular circuitry. The subsequent interactions between the injury site, neurons, and glia cells lead to increased excitability and persistent pain. Proinflammatory cytokines are also induced after injury, and may act on neurons to facilitate central sensitization and hyperalgesia. Recent findings implicate IL-1β in painful and
Acknowledgments
Dr. Ken Ren's work is supported by NIH grants DE11964, DE15374, NS060735. We thank Drs. Susan Croll and Lynn Macdonald for critical reading of this manuscript.
References (96)
- et al.
Disruption of P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Pain
(2005) - et al.
Expression of interleukin-1 beta in rat dorsal root ganglia
J. Neuroimmunol.
(2001) - et al.
The role of neuroinflammation and neuroimmune activation in persistent pain
Pain
(2001) Biological basis for Interleukin-1 in disease
Blood
(1996)Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation
Curr. Opin. Pharmacol.
(2004)- et al.
Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat
Brain Res.
(1994) - et al.
Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1-receptor antagonist
Lancet
(2004) - et al.
Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain
Neurobiol. Dis.
(2001) - et al.
Interleukin-1 increases stability and transcription of mRNA encoding nerve growth factor in culture rat fibroblasts
J. Biol. Chem.
(1988) - et al.
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses
Neuroscience
(2007)
Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats
Brain Res.
Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats
Brain Res.
NMDA receptor subunits: function and pharmacology
Curr. Opin. Pharmacol.
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat
Eur. J. Pain
Interleukin-1 activity in lesioned nerve
J. Neuroimmunol.
The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation
Neuropharmacology
Effect of cytokines on neuronal excitability
Neurosci. Lett.
Combined epineural therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice
Neurosci. Lett.
Immunity
Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia
Neurosci. Lett.
Neutralizing antibodies to interleukin-1 receptor reduce pain associated behavior in mice with experimental neuropathy
Neurosci. Lett.
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain
Neuroscience
Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies
J. Biol. Chem.
Cytokine regulation in animal models of neuropathic pain and human diseases
Neurosci. Lett.
Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain
Brain Behav. Immun.
Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study
Neuroscience
Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment
Brain Res.
Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammation
Neurosci. Lett.
Characterization of cytokine-induced hyperalgesia
Brain Res.
Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states
Pain
Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice
Pain
Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission
Brain Res.
Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain
Pain
Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia
Pain
IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats
Pain
Role of protein kinase A in phosphorylation of NMDA receptor 1 subunits in dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats
Neuroscience
NALP3 forms an IL-1β processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder
Immunity
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention
Nat. Rev., Drug Discov.
Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons
Eur. J. Neurosci.
Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation
Mol. Pain
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
J. Clin. Invest.
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation
Nature
Primer: inflammasomes and interleukin-1β in inflammatory disorders
Nat. Clin. Pract. Rheumatol.
Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation
J. Neurochem.
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
Br. J. Pharmacol.
Mechanism of inflammation in gout
Rheumatology
Interleukin 1 (IL-1) as a mediator of crystal arthritis
J. Immunol.
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Nat. Med.
Cited by (533)
Fabrication and evaluation of CMC-Ag and CMC-Zn-based composite films as biobased wound dressings
2024, Carbohydrate Polymer Technologies and ApplicationsRole of macrophages in trigeminal ganglia in ectopic orofacial pain associated with pulpitis
2024, Journal of Oral BiosciencesUp-scalable approaches for yeast mannan oligosaccharides (MOS) production: characterization and immunomodulatory properties
2024, Food and Bioproducts ProcessingPsilocybin and eugenol prevent DSS-induced neuroinflammation in mice
2024, Biocatalysis and Agricultural BiotechnologyThou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
2023, Advanced Drug Delivery Reviews